209 related articles for article (PubMed ID: 11152656)
1. Mouse models for the Wolf-Hirschhorn deletion syndrome.
Näf D; Wilson LA; Bergstrom RA; Smith RS; Goodwin NC; Verkerk A; van Ommen GJ; Ackerman SL; Frankel WN; Schimenti JC
Hum Mol Genet; 2001 Jan; 10(2):91-8. PubMed ID: 11152656
[TBL] [Abstract][Full Text] [Related]
2. On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review.
Zollino M; Murdolo M; Marangi G; Pecile V; Galasso C; Mazzanti L; Neri G
Am J Med Genet C Semin Med Genet; 2008 Nov; 148C(4):257-69. PubMed ID: 18932124
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2.
Zollino M; Lecce R; Fischetto R; Murdolo M; Faravelli F; Selicorni A; Buttè C; Memo L; Capovilla G; Neri G
Am J Hum Genet; 2003 Mar; 72(3):590-7. PubMed ID: 12563561
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome.
Zollino M; Di Stefano C; Zampino G; Mastroiacovo P; Wright TJ; Sorge G; Selicorni A; Tenconi R; Zappalà A; Battaglia A; Di Rocco M; Palka G; Pallotta R; Altherr MR; Neri G
Am J Med Genet; 2000 Sep; 94(3):254-61. PubMed ID: 10995514
[TBL] [Abstract][Full Text] [Related]
5. The etiology of Wolf-Hirschhorn syndrome.
Bergemann AD; Cole F; Hirschhorn K
Trends Genet; 2005 Mar; 21(3):188-95. PubMed ID: 15734578
[TBL] [Abstract][Full Text] [Related]
6. Clinical and epilepsy characteristics in Wolf-Hirschhorn syndrome (4p-): A review.
Paprocka J; Kaminiów K; Yetkin O; Tekturk P; Baykan B; Leiz S; Kluger G; Striano P
Seizure; 2024 Mar; 116():14-23. PubMed ID: 36526544
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Wolf-Hirschhorn syndrome phenotype: WHSC1 is a neurodevelopmental gene contributing to growth delay, intellectual disability, and to the facial dysmorphism.
Zollino M; Doronzio PN
J Hum Genet; 2018 Aug; 63(8):859-861. PubMed ID: 29884796
[No Abstract] [Full Text] [Related]
8. The new Wolf-Hirschhorn syndrome critical region (WHSCR-2): a description of a second case.
Rodríguez L; Zollino M; Climent S; Mansilla E; López-Grondona F; Martínez-Fernández ML; Murdolo M; Martínez-Frías ML
Am J Med Genet A; 2005 Jul; 136(2):175-8. PubMed ID: 15948183
[TBL] [Abstract][Full Text] [Related]
9. High resolution characterization of an interstitial deletion of less than 1.9 Mb at 4p16.3 associated with Wolf-Hirschhorn syndrome.
Fang YY; Bain S; Haan EA; Eyre HJ; MacDonald M; Wright TJ; Altherr MR; Riess O; Sutherland G; Callen DF
Am J Med Genet; 1997 Sep; 71(4):453-7. PubMed ID: 9286454
[TBL] [Abstract][Full Text] [Related]
10. Mild Wolf-Hirschhorn phenotype and partial GH deficiency in a patient with a 4p terminal deletion.
Titomanlio L; Romano A; Conti A; Genesio R; Salerno M; De Brasi D; Nitsch L; Del Giudice E
Am J Med Genet A; 2004 Jun; 127A(2):197-200. PubMed ID: 15108211
[TBL] [Abstract][Full Text] [Related]
11. First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype-phenotype correlation.
Rauch A; Schellmoser S; Kraus C; Dörr HG; Trautmann U; Altherr MR; Pfeiffer RA; Reis A
Am J Med Genet; 2001 Apr; 99(4):338-42. PubMed ID: 11252005
[TBL] [Abstract][Full Text] [Related]
12. From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.
Wiel LC; Bruno I; Barbi E; Sirchia F
Ital J Pediatr; 2022 May; 48(1):72. PubMed ID: 35550183
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of a novel gene from the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome critical region.
Wright TJ; Costa JL; Naranjo C; Francis-West P; Altherr MR
Genomics; 1999 Jul; 59(2):203-12. PubMed ID: 10409432
[TBL] [Abstract][Full Text] [Related]
14. The 4P-syndrome. Case description and literature review.
Moretti P; Ferrari M; Di Battista S; Di Battista C
Minerva Pediatr; 2001 Feb; 53(1):23-8. PubMed ID: 11309539
[TBL] [Abstract][Full Text] [Related]
15. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
16. Delimiting the Wolf-Hirschhorn syndrome critical region to 750 kilobase pairs.
Altherr MR; Wright TJ; Denison K; Perez-Castro AV; Johnson VP
Am J Med Genet; 1997 Jul; 71(1):47-53. PubMed ID: 9215768
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical characterization of a patient with a chromosome 4p deletion, Wolf-Hirschhorn syndrome, and congenital glaucoma.
Finzi S; Pinto CF; Wiggs JL
Ophthalmic Genet; 2001 Mar; 22(1):35-41. PubMed ID: 11262648
[TBL] [Abstract][Full Text] [Related]
18. Preliminary phenotypic map of chromosome 4p16 based on 4p deletions.
Estabrooks LL; Rao KW; Driscoll DA; Crandall BF; Dean JC; Ikonen E; Korf B; Aylsworth AS
Am J Med Genet; 1995 Jul; 57(4):581-6. PubMed ID: 7573133
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic manifestations of Wolf-Hirschhorn syndrome.
Wu-Chen WY; Christiansen SP; Berry SA; Engel WK; Fray KJ; Summers CG
J AAPOS; 2004 Aug; 8(4):345-8. PubMed ID: 15314595
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
